Loading data for STOK — first visit, this takes a few seconds.
Stoke Therapeutics Inc. (STOK)
NasdaqGS: STOK
· Real-Time Price · USD
32.29
+0.89 (2.83%)
At close: Aug 21, 2026, 8:00 PM
32.45
+0.50%
After-hours: 7:10 PM
The price, the headline numbers and the latest news, in one place.
Stoke Therapeutics Inc. (STOK) Stock Price, Analysis & Data
2.83% (1D)
No data available
| Bid | 32.12 |
| Market Cap | 2.08B |
| Revenue (ttm) | 27.59M |
| Net Income (ttm) | -207.9M |
| 1.23 | |
| -3.39 | |
| n/a | |
| -9.19 | |
| P/B (ttm) | 5.83 |
| P/S (ttm) | 75.52 |
| Earnings Date | Nov 3, 2026 |
| Ask | 40.96 |
| Volume | 891,874 |
| Avg. Volume (20D) | 826,069 |
| Open | 31.76 |
| Previous Close | 31.40 |
| Day's Range | 31.52 - 32.77 |
| 52-Week Range | 18.00 - 40.22 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About STOK
Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 19, 2019
Employees 170
Stock Exchange NasdaqGS
Ticker Symbol STOK
Financial Performance
In 2025, Stoke Therapeutics's revenue was 184.42M, an increase of 404.5% compared to the previous year's 36.55M. Earnings were -6.88M, a decrease of -92.26%.
Financial StatementsEarnings Surprise
Stoke Therapeutics has released their quarterly earnings on Aug 3, 2026:
- Revenue of $9.32M misses estimates by $0, with -32.51% YoY decline.
- EPS of -0.93 misses estimates by -0.15, with -132.50% YoY decline.
Stoke Therapeutics Inc. is scheduled to release its earnings on Nov 3, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2